Delivery Order SPE2DB22D3301-SPE2DB24FY7JB
- Not listed
- This federal contract award, with a value of $1,045.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566555611 - Norepinephrine 4 mg/4 ml vial, 4 ml, with a performance period ending on November 27, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,532.55, is for the delivery of 4 mg/4 ml vials of norepinephrine, a critical medication used in various medical treatments. The contract is a Firm Fixed Price Delivery Order that runs through February 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,325.44 firm fixed-price delivery order is for the supply of 4,568,004,494 units of 4 mg/4 ml vials of the drug norepinephrine. The contract has an ultimate completion date of April 24, 2025 and was awarded on April 23, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Norepinephrine 4 mg/4 ml vials, a medical product used for various healthcare applications. The award has a ceiling value of $1,013.75 and a period of performance through June 25, 2025. The contract is not designated as a set-aside and is open to full and open competition....
- This federal contract award is for the delivery of 4 mg/4 ml vials of the pharmaceutical drug norepinephrine, with a ceiling value of $2,008.70. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of norepinephrine 8 mg/250 ml-D5W 250ml. The contract, valued at $2,796.06, is a firm fixed-price delivery order with a completion date of July 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- This is a federal contract award for $5,364.11 made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,336,075 units of norepinephrine 4 mg/4 ml vials, a critical medical product used in healthcare settings. The award is a Delivery Order issued under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
- This federal contract award, SPE2DX15D3012|SPE2DX24F8VJ5, was made by the U.S. Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,927.08 firm fixed-price delivery order is for the supply of 4,565,846,958 units of 4 mg/4 ml norepinephrine vials. The contract has no set-aside designation and an ultimate completion date of September 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of norepinephrine 4 mg/4 ml vials to the U.S. Department of Defense (DoD) through the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, which is a subsidiary of the parent company Cencora, Inc. The contract, valued at $4,196.30, is a delivery order with a firm fixed price. It has an ultimate completion date of October 22, 2021 and was awarded on...
- This contract award is for the delivery of 4 mg/4 mL vials of the medication norepinephrine to the Defense Logistics Agency (DLA) Troop Support Medical, a significant customer of the prime contractor Amerisourcebergen Drug Corp. The contract has a ceiling value of $1,071.00 and an ultimate completion date of September 25, 2024. It is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds several large...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY7JBDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the supply of Norepinephrine 4 mg/4 ml vials. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $3,578.89, and has a completion date of May 28, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials, to support the U.S. Armed Forces and other government agencies. This contract award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 5/24/24 |